Project Grant R61DA065247
- Federal Grant Award Summary The University of Alabama at Birmingham received a $129,132 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 19, 2025 through October 31, 2027. This award supports molecular and functional characterization research of transcriptionally defined subpopulations of ventral tegmental area (VTA) dopamine neurons. The research investigates the distinct neurobiological roles...
- Federal Grant Award Summary Duke University received a $363,362 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. The award supports the development and testing of behavioral intervention protocols designed to address post-incarceration substance use and related health outcomes among individuals with opioid use disorders. The research initiative integrates evidence-based...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Alabama at Birmingham $2,061,312 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the mechanisms of operant reward seeking in prefrontal somatostatin-expressing interneurons. The award, issued April 15, 2025, with completion targeted for February 28, 2030, supports basic neuroscience research designed to advance understanding of how gamma-aminobutyric...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Alabama at Birmingham $1,465,275 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on the molecular mechanisms by which HIV and HIV proteins enhance amphetamine use disorder (AUD) escalation. The research project, initiated May 1, 2025 and extending through March 31, 2030, addresses a critical knowledge gap in understanding the bidirectional relationship...
- Federal Grant Award Summary The University of Miami received a $677,248 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial (RCT) testing the Comprehensive Telehealth Concierge (C-THR) model. The award, effective February 15, 2026, through December 31, 2030, focuses on improving HIV prevention and substance use disorder treatment engagement among individuals with histories...
- Federal Grant Award Summary The University of Miami's Office of Research Administration received a $793,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 1, 2026, for a project period extending through January 31, 2031. The award funds STRIVES (Status-Neutral Tele-Health Concierge Intervention for People Who Use Drugs via Engagement Through Street Medicine), a comprehensive telehealth-based care...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
- Federal Grant Award Summary The University of Massachusetts Medical School received a $2.19 million Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the five-year "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" randomized controlled trial. Beginning September 1, 2025, and concluding May 31, 2030, this research initiative will evaluate the effectiveness of the Maintaining...
- Federal Grant Award Summary The University of Maryland, Baltimore received a $219,291 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 30, 2025, with a completion date of July 31, 2028. The award funds the INSPIRE (Integrated Services for PWID Using Person-Centered Interactions, Reach, and Engagement) study, an implementation science initiative designed to develop and evaluate an integrated...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $248,990 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) for the period September 16, 2025 through August 31, 2028. This research initiative investigates the neurobiological mechanisms linking sleep and circadian disruptions to opioid use disorder (OUD) relapse and evaluates bright light therapy as a non-pharmacological intervention....
The University of Alabama at Birmingham received a $447,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective April 1, 2026 through March 31, 2028. This research project delivers a comprehensive intervention program integrating individually tailored behavioral activation (IT-BA) therapy into the Formerly Incarcerated Transition (FIT) Program, a reentry primary care initiative enhanced with peer support services. The deliverables include qualitative research identifying implementation barriers and facilitators, development of an IT-BA integration protocol for primary care settings, and a randomized controlled trial (RCT) evaluating the feasibility, acceptability, and initial efficacy of the combined intervention with 80 formerly incarcerated adults with current illicit drug use disorders. This award addresses critical post-release health risks among people who use drugs, including overdose, suicide, and infectious disease. The project specifically targets previously incarcerated individuals through a three-aim research design: conducting qualitative interviews with 15 formerly incarcerated persons who use drugs and 15 community stakeholders; developing an evidence-based integration protocol informed by expert mentors and community advisory board input; and implementing a six-month treatment outcomes assessment with participants randomly assigned to either IT-BA plus FIT (n=40) or FIT standard care (n=40). The research is positioned to advance implementation science within the substance use disorder prevention and treatment domain while addressing health disparities among criminal justice-involved populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $447.0k | 3/18/26 |